Designing vaccines for developing-country populations: ideal attributes, delivery devices, and presentation formats Fulltext Access 5 Pages 2010
Virus-Like Particles as vaccine antigens and adjuvants: application to chronic disease, cancer immunotherapy and infectious disease preventive strategies Fulltext Access 6 Pages 2010
Incorporating Cholera Vaccine Herd Protection into Economic Cost-Benefit and Cost-Effectiveness Models Fulltext Access 7 Pages 2010
Influenza Vaccine Production Capacity Building in Developing Countries: Example of the Serum Institute of India Fulltext Access 6 Pages 2010
Antibodies in the protection against mycobacterial infections: what have we learned? Fulltext Access 6 Pages 2010